Structure Therapeutics Inc.’s shares rose after more data on the company’s experimental weight-loss pill showed it’s shaping up to rival new oral treatments from Novo Nordisk A/S and Eli Lilly & Co.
March 16 (Reuters) - Structure Therapeutics' oral obesity drug aleniglipron delivered up to 16.3% weight loss when compared with a placebo after 44 weeks of treatment in a mid‑stage study, it said on ...
Evacuation orders were issued for a number of towns across Oklahoma on Friday as wildfires burned across the state. >> Open the video player above to watch the latest coverage from KOCO 5 Chief ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results